Higher dose statin drugs had a 0.17% greater reduction in arterial plaque than low-dose statins in diabetic patients, according to a report at the American College of Cardiology annual meeting. The TACT trial looking at EDTA Chelation Therapy had a much bigger improvement than that. I am not sure why most cardiologists still fail to accept such a great therapy.
See Family Practice News, April 1, 2013, p. 16-17.
Celebration of Health Association website